Literature DB >> 11337182

Trichosporon species infection in bone marrow transplanted patients.

M L Moretti-Branchini1, K Fukushima, A Z Schreiber, K Nishimura, P M Papaiordanou, P Trabasso, R Tanaka, M Miyaji.   

Abstract

Trichosporon species are emerging as opportunistic agents that cause systemic diseases in immunocompromised patients. Patients undergoing bone marrow transplant are submitted to intense and prolonged periods of neutropenia and consequently to several risk factors to fungal infections as the use of broad spectrum antibiotics and invasive devices. Two cases of fungal infections caused by Trichosporon asahii var. asahii and T. inkin in patients with bone marrow transplant are described T. asahii var. asahii was responsible for fungemia and the identification of this microorganism was later performed. T. inkin caused vascular accesses infection and was recovered from an implanted Hickman-Broviac catheter. Both patients were under oral fluconazole prophylaxis. The patient with systemic infection died despite the therapy with amphotericin B and the patient with catheter-related infection recovered from the fungal infection after catheter removal. Difficulties in the identification of this microorganism lead to delays in treatment and post-mortem diagnosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337182     DOI: 10.1016/s0732-8893(01)00215-2

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  28 in total

1.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism.

Authors:  Jose M Ramos; Manuel Cuenca-Estrella; Felix Gutierrez; Matilde Elia; Juan L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts.

Authors:  Carolina Serena; Francisco Javier Pastor; Montserrat Ortoneda; Javier Capilla; Nicole Nolard; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

Review 4.  Extensive white piedra of the scalp caused by Trichosporon inkin: A case report and review of literature.

Authors:  M R Shivaprakash; Gagandeep Singh; Prerna Gupta; Manpreet Dhaliwal; A J Kanwar; A Chakrabarti
Journal:  Mycopathologia       Date:  2011-08-11       Impact factor: 2.574

5.  Microbiological characteristics of medically important Trichosporon species.

Authors:  Hou-Min Li; Hong-Tao Du; Wei Liu; Zhe Wan; Ruo-Yu Li
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

6.  Sternal wound infection by Trichosporon inkin following cardiac surgery.

Authors:  Frances Davies; Sarah Logan; Elizabeth Johnson; John L Klein
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

7.  Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.

Authors:  Carolina Serena; Félix Gilgado; Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 8.  Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.

Authors:  Corrado Girmenia; Livio Pagano; Bruno Martino; Domenico D'Antonio; Rosa Fanci; Giorgina Specchia; Lorella Melillo; Massimo Buelli; Giampaolo Pizzarelli; Mario Venditti; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 9.  Update on the genus Trichosporon.

Authors:  Thomas C Chagas-Neto; Guilherme M Chaves; Arnaldo L Colombo
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

10.  Trichosporon inkin peritonitis treated with caspofungin.

Authors:  Miguel G Madariaga; Allan Tenorio; Laurie Proia
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.